US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site
Patent 12103976 was granted and assigned to invoX Pharma on October, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
